Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT00750880
Registration number
NCT00750880
Ethics application status
Date submitted
10/09/2008
Date registered
11/09/2008
Date last updated
22/07/2015
Titles & IDs
Public title
An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.
Query!
Scientific title
International Multi-Center Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have An Inadequate Response to Current Non-Biologic DMARD or Anti-TNF Therapy.
Query!
Secondary ID [1]
0
0
2008-000587-17
Query!
Secondary ID [2]
0
0
MA21573
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Rheumatoid Arthritis
0
0
Query!
Condition category
Condition code
Musculoskeletal
0
0
0
0
Query!
Osteoarthritis
Query!
Inflammatory and Immune System
0
0
0
0
Query!
Rheumatoid arthritis
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - tocilizumab [RoActemra/Actemra]
Experimental: 1 -
Treatment: Drugs: tocilizumab [RoActemra/Actemra]
8mg/kg iv (60 minute infusion)
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Percentage of Participants With Adverse Events (AEs): Overall Summary
Query!
Assessment method [1]
0
0
Percentage of participants with AEs, serious AEs (SAEs), related AEs, related SAEs, severe AEs, with AEs leading to withdrawal or dose modification, with infection, serious infection, infusion reactions, infusion reactions during an infusion, infusion reactions within 24 hours of an infusion, major adverse cardiac event (MACE), or death.
Query!
Timepoint [1]
0
0
Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [1]
0
0
Percentage of Participants Who Achieved Low Disease Activity or Remission Based on Disease Activity Score Based on 28-Joints Count (DAS28) by Visit
Query!
Assessment method [1]
0
0
DAS28 calculated from the number of swollen joints and tender joints using the 28 joints count, the erythrocyte sedimentation rate (ESR) (millimeters per hour [mm/hr]) and Patient's Global Assessment of Disease Activity (participant-rated arthritis activity assessment) with transformed scores ranging 0 to 10; higher scores indicated greater affectation due to disease activity. Low disease activity was defined as DAS28 less than or equal to (=)3.2 and remission was defined as DAS28 less than (<)2.6.
Query!
Timepoint [1]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [2]
0
0
Time to Low Disease Activity or Remission Based on DAS28 - Number of Participants With an Event
Query!
Assessment method [2]
0
0
DAS28 calculated from the number of swollen joints and tender joints using the 28 joints count, the ESR (mm/hr) and Patient's Global Assessment of Disease Activity (participant-rated arthritis activity assessment) with transformed scores ranging 0 to 10; higher scores indicated greater affectation due to disease activity. Low disease activity was defined as DAS28 =3.2 and remission was defined as DAS28 <2.6.
Query!
Timepoint [2]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [3]
0
0
Time to Low Disease Activity and Remission Based on DAS28 Score - Time to Event
Query!
Assessment method [3]
0
0
The time to low disease activity or remission was calculated as the number of days from study Day 1 to the first occurrence of low disease activity or remission. Participants who did not achieve low disease activity on or before Week 24 or who withdrew from the study prior to achieving low disease activity were considered censored. DAS28 calculated from the number of swollen joints and tender joints using the 28 joints count, the ESR (mm/hr) and Patient's Global Assessment of Disease Activity (participant-rated arthritis activity assessment) with transformed scores ranging 0 to 10; higher scores indicated greater affectation due to disease activity. Low disease activity defined as DAS28 =3.2 and remission defined as DAS28 <2.6.
Query!
Timepoint [3]
0
0
Baseline,Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [4]
0
0
Percentage of Participants Achieving a Response by European League Against Rheumatism (EULAR) Response Category and Visit
Query!
Assessment method [4]
0
0
DAS28-based EULAR response criteria were used to measure individual response as none, good, and moderate, depending on the extent of change from baseline and the level of disease activity reached. Good responders: change from baseline >1.2 with DAS28 =3.2; moderate responders: change from baseline >1.2 with DAS28 >3.2 to =5.1 or change from baseline >0.6 to =<1.2 with DAS28 =5.1; non-responders: change from baseline =0.6 or change from baseline >0.6 and =1.2 with DAS28 >5.1. If the EULAR response could not be determined, it was set to 'No response'.
Query!
Timepoint [4]
0
0
Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [5]
0
0
DAS28 Scores by Visit
Query!
Assessment method [5]
0
0
DAS28 calculated from the number of swollen joints and tender joints using the 28 joints count, the ESR (mm/hr) and Patient's Global Assessment of Disease Activity (participant-rated arthritis activity assessment) with transformed scores ranging 0 to 10; higher scores indicated greater affectation due to disease activity. A negative change from baseline indicates improvement.
Query!
Timepoint [5]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [6]
0
0
Percentage of Participants Achieving an American College of Rheumatology 20 Percent (%), 50%, 70%, or 90% Improvement (ACR20/ACR50/ACR70/ACR90) by Visit
Query!
Assessment method [6]
0
0
ACR20, ACR50, ACR70, and ACR90 are defined as =20%, =50%, =70%, or =90% improvement, respectively, in: swollen joint count (SJC; 66 joints) and tender joint count (TJC; 68 joints) and =20%, =50%, =70%, or =90% improvement, respectively, in 3 of following 5 assessments: Patient's Global Assessment of Pain (visual analog scale [VAS]); Patient's Global Assessment of Disease Activity (VAS); Investigator/Physician's Global Assessment of Disease Activity (VAS); participant's assessment of disability measured by the Health Assessment Questionnaire Disability Index (HAQ-DI); or acute phase reactant (ESR or C-reactive protein [CRP]). Participants who did not have the required data to assess ACR status at a given visit were classified as non-responders.
Query!
Timepoint [6]
0
0
Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [7]
0
0
Time to Achieve ACR20, ACR50, ACR70 and ACR90 Response - Number of Participants With an Event
Query!
Assessment method [7]
0
0
ACR20, ACR50, ACR70, and ACR90 are defined as =20%, =50%, =70%, or =90% improvement, respectively, in: swollen joint count (SJC; 66 joints) and tender joint count (TJC; 68 joints) and =20%, =50%, =70%, or =90% improvement, respectively, in 3 of following 5 assessments: Patient's Global Assessment of Pain (VAS); Patient's Global Assessment of Disease Activity (VAS); Investigator/Physician's Global Assessment of Disease Activity (VAS); participant's assessment of disability measured by the HAQ-DI; or acute phase reactant (ESR or CRP).
Query!
Timepoint [7]
0
0
Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [8]
0
0
Time to Achieve ACR20, ACR50, ACR70 and ACR90 Response
Query!
Assessment method [8]
0
0
ACR20, ACR50, ACR70, and ACR90 are defined as =20%, =50%, =70%, or =90% improvement, respectively, in: swollen joint count (SJC; 66 joints) and tender joint count (TJC; 68 joints) and =20%, =50%, =70%, or =90% improvement, respectively, in 3 of following 5 assessments: Patient's Global Assessment of Pain (VAS); Patient's Global Assessment of Disease Activity (VAS); Investigator/Physician's Global Assessment of Disease Activity (VAS); participant's assessment of disability measured by the HAQ-DI; or acute phase reactant (ESR or CRP). Time to ACR response was calculated as the number of days from day 1 of study to the date of first achievement of ACR response. Data represent median time for responders only.
Query!
Timepoint [8]
0
0
Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [9]
0
0
Swollen Joint Count by Visit
Query!
Assessment method [9]
0
0
Number of swollen joints was determined by examination of 66 joints and identifying when swelling was present. The number of swollen joints was recorded on the joint assessment form at each visit, no swelling = 0, swelling =1; total was calculated by adding all the joints for a maximum score of 66. A negative change from baseline indicates improvement.
Query!
Timepoint [9]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [10]
0
0
Tender Joint Count by Visit
Query!
Assessment method [10]
0
0
Number of tender joints was determined by examining 68 joints and identified the joints that were painful under pressure or to passive motion. The number of tender joints was recorded on the joint assessment form at each visit, no tenderness = 0, tenderness = 1; total was calculated by adding all the joints for a maximum score of 68. A negative change from baseline indicates improvement.
Query!
Timepoint [10]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [11]
0
0
Patient's Global Assessment of Disease Activity by Visit
Query!
Assessment method [11]
0
0
The participant's global assessment of disease activity is assessed on a 0 to 100 mm horizontal VAS by the participant. The left-hand extreme of the line=0 mm, and is described as "no disease activity" (symptom-free and no arthritis symptoms) and the right-hand extreme=100 mm, as "maximum disease activity" (maximum arthritis disease activity). The line was marked by the participant and the distance from the left edge was recorded. A negative change from baseline indicated improvement.
Query!
Timepoint [11]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [12]
0
0
Physician's Global Assessment of Disease Activity by Visit
Query!
Assessment method [12]
0
0
The physician's global assessment of disease activity is assessed on a 0 to 100 mm horizontal VAS by the physician. The left-hand extreme of the line=0 mm, and is described as "no disease activity" (symptom-free and no arthritis symptoms) and the right-hand extreme=100 mm as "maximum disease activity" (maximum arthritis disease activity). The physician marked the line and the distance from the left edge was recorded. A negative change from baseline indicated improvement.
Query!
Timepoint [12]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [13]
0
0
Patient's Global Assessment of Pain by Visit
Query!
Assessment method [13]
0
0
The participants assessed their pain using a 0 to 100 mm horizontal VAS. The left-hand extreme of the line=0 mm, and is described as "no pain" and the right-hand extreme=100 mm as "unbearable pain". The participant marked the line and the distance from the left edge was recorded. A negative change from baseline indicated improvement.
Query!
Timepoint [13]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [14]
0
0
C-Reactive Protein by Visit
Query!
Assessment method [14]
0
0
The test for CRP (mg per deciliter [mg/dL]) is a laboratory measurement for evaluation of an acute phase reactant of inflammation through the use of an ultrasensitive assay. A decrease in the level of CRP indicates reduction in inflammation and therefore improvement.
Query!
Timepoint [14]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [15]
0
0
Erythrocyte Sedimentation Rate by Visit
Query!
Assessment method [15]
0
0
ESR (mm/hr) is a blood test used to monitor therapy in inflammatory diseases such as rheumatoid arthritis (RA) and reflects acute phase reactant levels. Active disease in RA is defined by an ESR greater than 30 mm/hr. Change from baseline is computed as the value at each week minus the baseline value. A negative value in change from baseline indicates an improvement.
Query!
Timepoint [15]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [16]
0
0
HAQ-DI Scores by Visit
Query!
Assessment method [16]
0
0
HAQ-DI includes 20 questions concerning participant's activities of daily life, grouped in 8 scales of 2 to 3 questions for each activity. To respond to each question, a four-level response (score of 0 to 3 points), with higher scores showing larger functional limitations, was chosen. Scoring was as follows with respect to performance of participant's everyday activities: 0 (equals)=without difficulties; 1=with some difficulties; 2=with great difficulties; and 3=unable to perform these actions at all. Minimum score was 0, maximum score was 3.
Query!
Timepoint [16]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [17]
0
0
Short Form-36 (SF-36) Physical Functioning Domain Scores by Visit
Query!
Assessment method [17]
0
0
The SF-36 covers 8 health dimensions including 4 physical subscales (physical function, role-physical, bodily pain, and general health) and 4 mental subscales (vitality, social function, role-emotional, and mental health). The scores range from a minimum of 0 to a maximum of 100, with a higher score indicating better quality of life. Improvements of >3 points were considered clinically meaningful.
Query!
Timepoint [17]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [18]
0
0
Percentage of Participants With HAQ-DI Clinical Remission and Clinically Meaningful Improvement By Visit
Query!
Assessment method [18]
0
0
The HAQ-DI scale ranges from 0 to 3, where higher scores represent higher disease activity. A score of <0.5 represents clinical remission. A participant achieves a clinically meaningful improvement in HAQ-DI if they had a reduction from baseline of =0.22.
Query!
Timepoint [18]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Secondary outcome [19]
0
0
Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) Score by Visit
Query!
Assessment method [19]
0
0
FACIT-Fatigue is a 13-item questionnaire; participants scored each item on a 5-point scale: 0 (Not at all) to 4 (Very much). The larger the participant's response to the questions (with the exception of 2 negatively stated), the greater the participant's fatigue. The sum of all responses resulted in the FACIT-Fatigue score for a total possible score of 0 (worse score) to 52 (better score). A higher score reflects an improvement in the participant's health status.
Query!
Timepoint [19]
0
0
Baseline, Weeks 4, 8, 12, 16, 20, and 24
Query!
Eligibility
Key inclusion criteria
- male and non-pregnant or nursing female patients >=18 years of age;
- body weight <=150kg;
- moderate to severe active RA (DAS28 >=3.2) of >=6 months duration;
- on >=1 non-biologic DMARDs at a stable dose for a period of >= 8 weeks prior to start
of treatment;
- inadequate clinical response to a stable dose of non-biologic DMARD or anti-TNF
therapy;
- if receiving oral corticosteroids, the dose must have been stable for at least 25 of
28 days prior to start of treatment.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- major surgery (including joint surgery) within 8 weeks prior to screening or planned
major surgery within 6 months following enrollment;
- rheumatic autoimmune disease other than RA;
- prior history of, or current inflammatory joint disease other than RA;
- functional class IV as defined by the ACR Classification of Functional Status in RA.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/09/2008
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/07/2011
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
1681
Query!
Recruitment in Australia
Recruitment state(s)
ACT,NSW,SA,VIC
Query!
Recruitment hospital [1]
0
0
- Canberra
Query!
Recruitment hospital [2]
0
0
- Coffs Harbour
Query!
Recruitment hospital [3]
0
0
- Kogarah
Query!
Recruitment hospital [4]
0
0
- Parramatta Park
Query!
Recruitment hospital [5]
0
0
- Adelaide
Query!
Recruitment hospital [6]
0
0
- Fitzroy
Query!
Recruitment hospital [7]
0
0
- Geelong
Query!
Recruitment hospital [8]
0
0
- Melbourne
Query!
Recruitment postcode(s) [1]
0
0
2601 - Canberra
Query!
Recruitment postcode(s) [2]
0
0
2450 - Coffs Harbour
Query!
Recruitment postcode(s) [3]
0
0
2217 - Kogarah
Query!
Recruitment postcode(s) [4]
0
0
4870 - Parramatta Park
Query!
Recruitment postcode(s) [5]
0
0
5041 - Adelaide
Query!
Recruitment postcode(s) [6]
0
0
3065 - Fitzroy
Query!
Recruitment postcode(s) [7]
0
0
3220 - Geelong
Query!
Recruitment postcode(s) [8]
0
0
3168 - Melbourne
Query!
Recruitment outside Australia
Country [1]
0
0
Austria
Query!
State/province [1]
0
0
Graz-Eggenberg
Query!
Country [2]
0
0
Austria
Query!
State/province [2]
0
0
Graz
Query!
Country [3]
0
0
Austria
Query!
State/province [3]
0
0
Innsbruck
Query!
Country [4]
0
0
Austria
Query!
State/province [4]
0
0
Linz
Query!
Country [5]
0
0
Austria
Query!
State/province [5]
0
0
Salzburg
Query!
Country [6]
0
0
Austria
Query!
State/province [6]
0
0
Stockerau
Query!
Country [7]
0
0
Austria
Query!
State/province [7]
0
0
Wien
Query!
Country [8]
0
0
Belgium
Query!
State/province [8]
0
0
Aalst
Query!
Country [9]
0
0
Belgium
Query!
State/province [9]
0
0
Bruxelles
Query!
Country [10]
0
0
Belgium
Query!
State/province [10]
0
0
Edegem
Query!
Country [11]
0
0
Belgium
Query!
State/province [11]
0
0
Gent
Query!
Country [12]
0
0
Belgium
Query!
State/province [12]
0
0
Hasselt
Query!
Country [13]
0
0
Belgium
Query!
State/province [13]
0
0
Heusy
Query!
Country [14]
0
0
Belgium
Query!
State/province [14]
0
0
Leuven
Query!
Country [15]
0
0
Belgium
Query!
State/province [15]
0
0
Liege
Query!
Country [16]
0
0
Belgium
Query!
State/province [16]
0
0
Merksem
Query!
Country [17]
0
0
Belgium
Query!
State/province [17]
0
0
Montignies S/ Sambre
Query!
Country [18]
0
0
Belgium
Query!
State/province [18]
0
0
Westmalle
Query!
Country [19]
0
0
Canada
Query!
State/province [19]
0
0
Alberta
Query!
Country [20]
0
0
Canada
Query!
State/province [20]
0
0
British Columbia
Query!
Country [21]
0
0
Canada
Query!
State/province [21]
0
0
New Brunswick
Query!
Country [22]
0
0
Canada
Query!
State/province [22]
0
0
Newfoundland and Labrador
Query!
Country [23]
0
0
Canada
Query!
State/province [23]
0
0
Ontario
Query!
Country [24]
0
0
Canada
Query!
State/province [24]
0
0
Quebec
Query!
Country [25]
0
0
Canada
Query!
State/province [25]
0
0
Saskatchewan
Query!
Country [26]
0
0
Czech Republic
Query!
State/province [26]
0
0
Bruntal
Query!
Country [27]
0
0
Czech Republic
Query!
State/province [27]
0
0
Ostrava
Query!
Country [28]
0
0
Czech Republic
Query!
State/province [28]
0
0
Praha
Query!
Country [29]
0
0
Czech Republic
Query!
State/province [29]
0
0
Sokolov
Query!
Country [30]
0
0
Czech Republic
Query!
State/province [30]
0
0
Uherske Hradiste
Query!
Country [31]
0
0
Czech Republic
Query!
State/province [31]
0
0
Zlin
Query!
Country [32]
0
0
Denmark
Query!
State/province [32]
0
0
Esbjerg
Query!
Country [33]
0
0
Denmark
Query!
State/province [33]
0
0
Hjørring
Query!
Country [34]
0
0
Denmark
Query!
State/province [34]
0
0
København
Query!
Country [35]
0
0
Denmark
Query!
State/province [35]
0
0
Silkeborg
Query!
Country [36]
0
0
Denmark
Query!
State/province [36]
0
0
Århus
Query!
Country [37]
0
0
Finland
Query!
State/province [37]
0
0
Helsinki
Query!
Country [38]
0
0
Finland
Query!
State/province [38]
0
0
Jyvaeskylae
Query!
Country [39]
0
0
Finland
Query!
State/province [39]
0
0
Turku
Query!
Country [40]
0
0
France
Query!
State/province [40]
0
0
Argenteuil
Query!
Country [41]
0
0
France
Query!
State/province [41]
0
0
Aulnay Sous Bois
Query!
Country [42]
0
0
France
Query!
State/province [42]
0
0
Belfort
Query!
Country [43]
0
0
France
Query!
State/province [43]
0
0
Bobigny
Query!
Country [44]
0
0
France
Query!
State/province [44]
0
0
Bourg En Bresse
Query!
Country [45]
0
0
France
Query!
State/province [45]
0
0
Caen
Query!
Country [46]
0
0
France
Query!
State/province [46]
0
0
Cahors
Query!
Country [47]
0
0
France
Query!
State/province [47]
0
0
Colmar
Query!
Country [48]
0
0
France
Query!
State/province [48]
0
0
Corbeil-essonnes
Query!
Country [49]
0
0
France
Query!
State/province [49]
0
0
Dijon
Query!
Country [50]
0
0
France
Query!
State/province [50]
0
0
La Rochelle
Query!
Country [51]
0
0
France
Query!
State/province [51]
0
0
Lievin
Query!
Country [52]
0
0
France
Query!
State/province [52]
0
0
Lomme
Query!
Country [53]
0
0
France
Query!
State/province [53]
0
0
Lyon
Query!
Country [54]
0
0
France
Query!
State/province [54]
0
0
Marseille
Query!
Country [55]
0
0
France
Query!
State/province [55]
0
0
Montivilliers
Query!
Country [56]
0
0
France
Query!
State/province [56]
0
0
Montpellier
Query!
Country [57]
0
0
France
Query!
State/province [57]
0
0
Mulhouse
Query!
Country [58]
0
0
France
Query!
State/province [58]
0
0
Paris
Query!
Country [59]
0
0
France
Query!
State/province [59]
0
0
Pau
Query!
Country [60]
0
0
France
Query!
State/province [60]
0
0
Poitiers
Query!
Country [61]
0
0
France
Query!
State/province [61]
0
0
Reims
Query!
Country [62]
0
0
France
Query!
State/province [62]
0
0
Roubaix
Query!
Country [63]
0
0
France
Query!
State/province [63]
0
0
St Brieuc
Query!
Country [64]
0
0
France
Query!
State/province [64]
0
0
Strasbourg
Query!
Country [65]
0
0
France
Query!
State/province [65]
0
0
Toulouse
Query!
Country [66]
0
0
France
Query!
State/province [66]
0
0
Valence
Query!
Country [67]
0
0
France
Query!
State/province [67]
0
0
Valenciennes
Query!
Country [68]
0
0
Germany
Query!
State/province [68]
0
0
Berlin
Query!
Country [69]
0
0
Germany
Query!
State/province [69]
0
0
Bielefeld
Query!
Country [70]
0
0
Germany
Query!
State/province [70]
0
0
Freiburg
Query!
Country [71]
0
0
Germany
Query!
State/province [71]
0
0
Greifswald
Query!
Country [72]
0
0
Germany
Query!
State/province [72]
0
0
Hamburg
Query!
Country [73]
0
0
Germany
Query!
State/province [73]
0
0
Jena
Query!
Country [74]
0
0
Germany
Query!
State/province [74]
0
0
Kiel
Query!
Country [75]
0
0
Germany
Query!
State/province [75]
0
0
Rostock
Query!
Country [76]
0
0
Germany
Query!
State/province [76]
0
0
Saarbruecken
Query!
Country [77]
0
0
Germany
Query!
State/province [77]
0
0
Wuerzburg
Query!
Country [78]
0
0
Germany
Query!
State/province [78]
0
0
Wuppertal
Query!
Country [79]
0
0
Greece
Query!
State/province [79]
0
0
Athens
Query!
Country [80]
0
0
Greece
Query!
State/province [80]
0
0
Heraklion
Query!
Country [81]
0
0
Greece
Query!
State/province [81]
0
0
Ioannina
Query!
Country [82]
0
0
Greece
Query!
State/province [82]
0
0
Patras
Query!
Country [83]
0
0
Greece
Query!
State/province [83]
0
0
Thessaloniki
Query!
Country [84]
0
0
Hungary
Query!
State/province [84]
0
0
Budapest
Query!
Country [85]
0
0
Hungary
Query!
State/province [85]
0
0
Eger
Query!
Country [86]
0
0
Hungary
Query!
State/province [86]
0
0
Gyula
Query!
Country [87]
0
0
Hungary
Query!
State/province [87]
0
0
Szeged
Query!
Country [88]
0
0
Hungary
Query!
State/province [88]
0
0
Veszprem
Query!
Country [89]
0
0
India
Query!
State/province [89]
0
0
Bangalore
Query!
Country [90]
0
0
India
Query!
State/province [90]
0
0
Chennai
Query!
Country [91]
0
0
India
Query!
State/province [91]
0
0
Hyderabad
Query!
Country [92]
0
0
India
Query!
State/province [92]
0
0
Jaipur
Query!
Country [93]
0
0
India
Query!
State/province [93]
0
0
Kolkata
Query!
Country [94]
0
0
India
Query!
State/province [94]
0
0
Ludhiana
Query!
Country [95]
0
0
India
Query!
State/province [95]
0
0
Mumbai
Query!
Country [96]
0
0
India
Query!
State/province [96]
0
0
New Delhi
Query!
Country [97]
0
0
India
Query!
State/province [97]
0
0
Pune
Query!
Country [98]
0
0
Ireland
Query!
State/province [98]
0
0
Co Leitrim
Query!
Country [99]
0
0
Ireland
Query!
State/province [99]
0
0
Cork
Query!
Country [100]
0
0
Ireland
Query!
State/province [100]
0
0
Dublin
Query!
Country [101]
0
0
Ireland
Query!
State/province [101]
0
0
Galway
Query!
Country [102]
0
0
Ireland
Query!
State/province [102]
0
0
Limerick
Query!
Country [103]
0
0
Ireland
Query!
State/province [103]
0
0
Waterford
Query!
Country [104]
0
0
Italy
Query!
State/province [104]
0
0
Arenzano
Query!
Country [105]
0
0
Italy
Query!
State/province [105]
0
0
Legnano
Query!
Country [106]
0
0
Italy
Query!
State/province [106]
0
0
Milano
Query!
Country [107]
0
0
Italy
Query!
State/province [107]
0
0
Modena
Query!
Country [108]
0
0
Italy
Query!
State/province [108]
0
0
Monserrato
Query!
Country [109]
0
0
Italy
Query!
State/province [109]
0
0
Novara
Query!
Country [110]
0
0
Italy
Query!
State/province [110]
0
0
Palermo
Query!
Country [111]
0
0
Italy
Query!
State/province [111]
0
0
Pescara
Query!
Country [112]
0
0
Italy
Query!
State/province [112]
0
0
Potenza
Query!
Country [113]
0
0
Italy
Query!
State/province [113]
0
0
Roma
Query!
Country [114]
0
0
Italy
Query!
State/province [114]
0
0
Siena
Query!
Country [115]
0
0
Italy
Query!
State/province [115]
0
0
Varese
Query!
Country [116]
0
0
Luxembourg
Query!
State/province [116]
0
0
Luxembourg
Query!
Country [117]
0
0
Netherlands
Query!
State/province [117]
0
0
'S Hertogenbosch
Query!
Country [118]
0
0
Netherlands
Query!
State/province [118]
0
0
Alkmaar
Query!
Country [119]
0
0
Netherlands
Query!
State/province [119]
0
0
Amsterdam
Query!
Country [120]
0
0
Netherlands
Query!
State/province [120]
0
0
Apeldoorn
Query!
Country [121]
0
0
Netherlands
Query!
State/province [121]
0
0
Arnhem
Query!
Country [122]
0
0
Netherlands
Query!
State/province [122]
0
0
Bergen Op Zoom
Query!
Country [123]
0
0
Netherlands
Query!
State/province [123]
0
0
Den Haag
Query!
Country [124]
0
0
Netherlands
Query!
State/province [124]
0
0
Den Helder
Query!
Country [125]
0
0
Netherlands
Query!
State/province [125]
0
0
Enschede
Query!
Country [126]
0
0
Netherlands
Query!
State/province [126]
0
0
Gorinchem
Query!
Country [127]
0
0
Netherlands
Query!
State/province [127]
0
0
Gouda
Query!
Country [128]
0
0
Netherlands
Query!
State/province [128]
0
0
Heerlen
Query!
Country [129]
0
0
Netherlands
Query!
State/province [129]
0
0
Hilversum
Query!
Country [130]
0
0
Netherlands
Query!
State/province [130]
0
0
Leeuwarden
Query!
Country [131]
0
0
Netherlands
Query!
State/province [131]
0
0
Leidschendam
Query!
Country [132]
0
0
Netherlands
Query!
State/province [132]
0
0
Nieuwegein
Query!
Country [133]
0
0
Netherlands
Query!
State/province [133]
0
0
Nijmegen
Query!
Country [134]
0
0
Netherlands
Query!
State/province [134]
0
0
Roosendaal
Query!
Country [135]
0
0
Netherlands
Query!
State/province [135]
0
0
Rotterdam
Query!
Country [136]
0
0
Netherlands
Query!
State/province [136]
0
0
Schiedam
Query!
Country [137]
0
0
Netherlands
Query!
State/province [137]
0
0
Spijkenisse
Query!
Country [138]
0
0
Netherlands
Query!
State/province [138]
0
0
Vlissingen
Query!
Country [139]
0
0
Poland
Query!
State/province [139]
0
0
Krakow
Query!
Country [140]
0
0
Poland
Query!
State/province [140]
0
0
Poznan
Query!
Country [141]
0
0
Poland
Query!
State/province [141]
0
0
Wroclaw
Query!
Country [142]
0
0
Portugal
Query!
State/province [142]
0
0
Almada
Query!
Country [143]
0
0
Portugal
Query!
State/province [143]
0
0
Coimbra
Query!
Country [144]
0
0
Portugal
Query!
State/province [144]
0
0
Lisboa
Query!
Country [145]
0
0
Portugal
Query!
State/province [145]
0
0
Porto
Query!
Country [146]
0
0
Romania
Query!
State/province [146]
0
0
Bucharest
Query!
Country [147]
0
0
Romania
Query!
State/province [147]
0
0
Cluj-napoca
Query!
Country [148]
0
0
Saudi Arabia
Query!
State/province [148]
0
0
Jeddah
Query!
Country [149]
0
0
Spain
Query!
State/province [149]
0
0
Alicante
Query!
Country [150]
0
0
Spain
Query!
State/province [150]
0
0
Avila
Query!
Country [151]
0
0
Spain
Query!
State/province [151]
0
0
Barcelona
Query!
Country [152]
0
0
Spain
Query!
State/province [152]
0
0
Cadiz
Query!
Country [153]
0
0
Spain
Query!
State/province [153]
0
0
La Coruña
Query!
Country [154]
0
0
Spain
Query!
State/province [154]
0
0
Las Palmas
Query!
Country [155]
0
0
Spain
Query!
State/province [155]
0
0
Leon
Query!
Country [156]
0
0
Spain
Query!
State/province [156]
0
0
Tenerife
Query!
Country [157]
0
0
Spain
Query!
State/province [157]
0
0
Almeria
Query!
Country [158]
0
0
Spain
Query!
State/province [158]
0
0
Caceres
Query!
Country [159]
0
0
Spain
Query!
State/province [159]
0
0
Cordoba
Query!
Country [160]
0
0
Spain
Query!
State/province [160]
0
0
Granada
Query!
Country [161]
0
0
Spain
Query!
State/province [161]
0
0
Huesca
Query!
Country [162]
0
0
Spain
Query!
State/province [162]
0
0
Lugo
Query!
Country [163]
0
0
Spain
Query!
State/province [163]
0
0
Madrid
Query!
Country [164]
0
0
Spain
Query!
State/province [164]
0
0
Malaga
Query!
Country [165]
0
0
Spain
Query!
State/province [165]
0
0
Murcia
Query!
Country [166]
0
0
Spain
Query!
State/province [166]
0
0
Orense
Query!
Country [167]
0
0
Spain
Query!
State/province [167]
0
0
Salamanca
Query!
Country [168]
0
0
Spain
Query!
State/province [168]
0
0
Sevilla
Query!
Country [169]
0
0
Spain
Query!
State/province [169]
0
0
Valencia
Query!
Country [170]
0
0
Spain
Query!
State/province [170]
0
0
Zaragoza
Query!
Country [171]
0
0
Sweden
Query!
State/province [171]
0
0
Falun
Query!
Country [172]
0
0
Sweden
Query!
State/province [172]
0
0
Huddinge
Query!
Country [173]
0
0
Sweden
Query!
State/province [173]
0
0
Karlstad
Query!
Country [174]
0
0
Sweden
Query!
State/province [174]
0
0
Linkoeping
Query!
Country [175]
0
0
Sweden
Query!
State/province [175]
0
0
Malmo
Query!
Country [176]
0
0
Sweden
Query!
State/province [176]
0
0
Skoevde
Query!
Country [177]
0
0
Sweden
Query!
State/province [177]
0
0
Stockholm
Query!
Country [178]
0
0
Sweden
Query!
State/province [178]
0
0
Uppsala
Query!
Country [179]
0
0
Sweden
Query!
State/province [179]
0
0
Västerås
Query!
Country [180]
0
0
Switzerland
Query!
State/province [180]
0
0
Aarau
Query!
Country [181]
0
0
Switzerland
Query!
State/province [181]
0
0
Basel
Query!
Country [182]
0
0
Switzerland
Query!
State/province [182]
0
0
Fribourg
Query!
Country [183]
0
0
Switzerland
Query!
State/province [183]
0
0
Genève
Query!
Country [184]
0
0
Switzerland
Query!
State/province [184]
0
0
Luzern
Query!
Country [185]
0
0
Switzerland
Query!
State/province [185]
0
0
St. Gallen
Query!
Country [186]
0
0
Switzerland
Query!
State/province [186]
0
0
Zürich
Query!
Country [187]
0
0
Turkey
Query!
State/province [187]
0
0
Ankara
Query!
Country [188]
0
0
Turkey
Query!
State/province [188]
0
0
Istanbul
Query!
Country [189]
0
0
United Kingdom
Query!
State/province [189]
0
0
Barnsley
Query!
Country [190]
0
0
United Kingdom
Query!
State/province [190]
0
0
Basingstoke
Query!
Country [191]
0
0
United Kingdom
Query!
State/province [191]
0
0
Bournemouth
Query!
Country [192]
0
0
United Kingdom
Query!
State/province [192]
0
0
Brighton
Query!
Country [193]
0
0
United Kingdom
Query!
State/province [193]
0
0
Burton on Trent
Query!
Country [194]
0
0
United Kingdom
Query!
State/province [194]
0
0
Bury St Edmonds
Query!
Country [195]
0
0
United Kingdom
Query!
State/province [195]
0
0
Cambridge
Query!
Country [196]
0
0
United Kingdom
Query!
State/province [196]
0
0
Cardiff
Query!
Country [197]
0
0
United Kingdom
Query!
State/province [197]
0
0
Chelmsford
Query!
Country [198]
0
0
United Kingdom
Query!
State/province [198]
0
0
Dudley
Query!
Country [199]
0
0
United Kingdom
Query!
State/province [199]
0
0
Dundee
Query!
Country [200]
0
0
United Kingdom
Query!
State/province [200]
0
0
Eastbourne
Query!
Country [201]
0
0
United Kingdom
Query!
State/province [201]
0
0
Gillingham
Query!
Country [202]
0
0
United Kingdom
Query!
State/province [202]
0
0
Harrogate
Query!
Country [203]
0
0
United Kingdom
Query!
State/province [203]
0
0
Huddersfield
Query!
Country [204]
0
0
United Kingdom
Query!
State/province [204]
0
0
Ipswich
Query!
Country [205]
0
0
United Kingdom
Query!
State/province [205]
0
0
Liverpool
Query!
Country [206]
0
0
United Kingdom
Query!
State/province [206]
0
0
Llantrisant
Query!
Country [207]
0
0
United Kingdom
Query!
State/province [207]
0
0
Londonderry
Query!
Country [208]
0
0
United Kingdom
Query!
State/province [208]
0
0
London
Query!
Country [209]
0
0
United Kingdom
Query!
State/province [209]
0
0
Maidstone
Query!
Country [210]
0
0
United Kingdom
Query!
State/province [210]
0
0
Middlesborough
Query!
Country [211]
0
0
United Kingdom
Query!
State/province [211]
0
0
Newcastle upon Tyne
Query!
Country [212]
0
0
United Kingdom
Query!
State/province [212]
0
0
Nottingham
Query!
Country [213]
0
0
United Kingdom
Query!
State/province [213]
0
0
Reading
Query!
Country [214]
0
0
United Kingdom
Query!
State/province [214]
0
0
Salford
Query!
Country [215]
0
0
United Kingdom
Query!
State/province [215]
0
0
Sheffield
Query!
Country [216]
0
0
United Kingdom
Query!
State/province [216]
0
0
Southport
Query!
Country [217]
0
0
United Kingdom
Query!
State/province [217]
0
0
Swindon
Query!
Country [218]
0
0
United Kingdom
Query!
State/province [218]
0
0
Torquay
Query!
Country [219]
0
0
United Kingdom
Query!
State/province [219]
0
0
Westcliffe-on-sea
Query!
Country [220]
0
0
United Kingdom
Query!
State/province [220]
0
0
Wirral
Query!
Country [221]
0
0
United Kingdom
Query!
State/province [221]
0
0
Worthing
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Query!
Name
Hoffmann-La Roche
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This open-label, single arm study will investigate the safety, tolerability and efficacy of
tocilizumab monotherapy, or combination therapy with non-biologic disease modifying
antirheumatic drugs (DMARDs), in patients with severe active RA. Patients will receive
tocilizumab 8mg/kg iv as a 60 minute infusion every 4 weeks for a total of 6 infusions. The
anticipated time on study treatment is 3-12 months, and the target sample size is >500
individuals.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT00750880
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Clinical Trials
Query!
Address
0
0
Hoffmann-La Roche
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT00750880
Download to PDF